Brief: Brii Biosciences Ltd Posts HY Loss Attributable Rmb347.6 Million
24/08/2022 02:30
Aug 24 (Reuters) - Brii Biosciences Ltd 2137.HK :
* HY LOSS ATTRIBUTABLE RMB347.6 MILLION VERSUS LOSS OF
RMB2.95
BILLION
* HY OTHER INCOME RMB38.2 MILLION VERSUS RMB46.3 MILLION
Source text for Eikon: ID:nHKS1MHm0
Further company coverage: 2137.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR